NFX

NUFORMIX PLC ORD 0.1P

TitleTime
Holding(s) in CompanyWed 06/05/20 | 15:30
Holding(s) in CompanyFri 03/04/20 | 15:31
Notiication of Major Share HoldingMon 30/03/20 | 15:42
Second Price Monitoring ExtnMon 09/03/20 | 16:42
Price Monitoring ExtensionMon 09/03/20 | 16:37
Appointment of Dr Karl KeeganTue 18/02/20 | 07:00
Second Price Monitoring ExtnFri 14/02/20 | 16:41
Price Monitoring ExtensionFri 14/02/20 | 16:35
Second Price Monitoring ExtnFri 14/02/20 | 14:05
Price Monitoring ExtensionFri 14/02/20 | 14:00
Second Price Monitoring ExtnThu 13/02/20 | 16:40
Price Monitoring ExtensionThu 13/02/20 | 16:35
Notification of Major HoldingsWed 12/02/20 | 16:10
Operational UpdateWed 05/02/20 | 17:05
Resignation of Dave TapolczayWed 05/02/20 | 16:45
Director DealingWed 05/02/20 | 14:24
Notification of Major HoldingsWed 05/02/20 | 14:19
Resignation of John LidgeyMon 27/01/20 | 07:00
Major Shareholding NotificationMon 27/01/20 | 07:00
Amendment to NoticeWed 15/01/20 | 12:43
Issue of EquityFri 10/01/20 | 11:45
Holding(s) in CompanyWed 08/01/20 | 08:17
Half-year ReportTue 24/12/19 | 07:00
Second Price Monitoring ExtnMon 25/11/19 | 16:41
Price Monitoring ExtensionMon 25/11/19 | 16:36
Update and Placing AnnouncementMon 25/11/19 | 07:00
Second Price Monitoring ExtnMon 28/10/19 | 14:05
Price Monitoring ExtensionMon 28/10/19 | 14:00
Issue of EquityMon 28/10/19 | 08:30
Statement re. Share Price MovementFri 25/10/19 | 11:11
Second Price Monitoring ExtnFri 25/10/19 | 09:05
Price Monitoring ExtensionFri 25/10/19 | 09:00
Second Price Monitoring ExtnFri 20/09/19 | 14:05
Price Monitoring ExtensionFri 20/09/19 | 14:00
AGM ResultsTue 10/09/19 | 16:49
Directorate ChangeTue 10/09/19 | 07:00
Ebers Cannabinoid Collaboration UpdateMon 09/09/19 | 07:00
Appointment of Dr Muhunthan ThillaiFri 06/09/19 | 07:30
Holding(s) in CompanyWed 04/09/19 | 07:30
Annual Financial ReportThu 01/08/19 | 09:30
Holding(s) in CompanyMon 29/07/19 | 07:00
Final ResultsThu 18/07/19 | 07:00
Holding(s) in CompanyFri 07/06/19 | 07:00
Holding(s) in CompanyThu 06/06/19 | 07:00
Second Price Monitoring ExtnThu 30/05/19 | 11:05
Price Monitoring ExtensionThu 30/05/19 | 11:00
Positive Results for NXP001 Clinical TrialThu 30/05/19 | 07:01
Holding(s) in Company - AmendmentTue 28/05/19 | 07:00
Loan ConversionFri 24/05/19 | 07:00
Holding(s) in CompanyWed 22/05/19 | 07:00
Holding(s) in CompanyWed 22/05/19 | 07:00
Holding(s) in CompanyWed 22/05/19 | 07:00
Second Price Monitoring ExtnWed 15/05/19 | 16:40
Price Monitoring ExtensionWed 15/05/19 | 16:35
Nuformix Achieves 2nd NXP001 Development MilestoneWed 15/05/19 | 07:00
Price Monitoring ExtensionFri 10/05/19 | 09:00
Holding(s) in CompanyWed 08/05/19 | 07:30
Second Price Monitoring ExtnTue 09/04/19 | 16:41
Price Monitoring ExtensionTue 09/04/19 | 16:35
Strategic Cannabinoid AgreementTue 09/04/19 | 07:00
Notification Major Share InterestsFri 05/04/19 | 07:00
Nuformix Commences NXP001 Clinical TrialFri 22/03/19 | 07:00
MHRA approval for NXP001Wed 27/02/19 | 07:00
Holding(s) in CompanyWed 20/02/19 | 18:16
Unaudited Half Year ResultsThu 20/12/18 | 07:00
Reports Results from Novel IPF Pre-Clinical TrialMon 03/12/18 | 07:00
Expansion of NXP001 Agreement & Milestone PaymentTue 27/11/18 | 07:00
Director/PDMR ShareholdingFri 28/09/18 | 10:09
Additional New NXP002 Patent FilingFri 28/09/18 | 07:00
Result of AGMWed 19/09/18 | 14:33
NXP001 Pre-Clinical Milestone AchievedFri 14/09/18 | 07:00
Convertible Loan AmendmentTue 28/08/18 | 12:55
Annual Report and Notice of AGMThu 16/08/18 | 07:00
Final ResultsThu 26/07/18 | 14:00
Holding(s) in CompanyMon 09/07/18 | 09:33
Operational UpdateMon 02/07/18 | 07:00
Collaboration with SGSCTue 26/06/18 | 08:00
Dr Chris Blackwell Appointed NEDFri 11/05/18 | 07:00
Holding(s) in CompanyTue 24/04/18 | 11:54
Stmnt re Share Price MovementWed 11/04/18 | 16:41
Update re: BrokerFri 02/03/18 | 13:30
Holding(s) in CompanyTue 27/02/18 | 09:37
NXP002 Pilot Study in Lung and Liver FibrosisWed 31/01/18 | 07:00
Agreement to License NXP001Fri 15/12/17 | 07:30
Dr Andy Richards Chairs Advisory Panel - New ApptsThu 14/12/17 | 07:00
Second Price Monitoring ExtnTue 12/12/17 | 16:40
Price Monitoring ExtensionTue 12/12/17 | 16:35
Grant of WarrantsWed 06/12/17 | 07:00
Appointment of BrokerFri 01/12/17 | 07:30
Holding(s) in CompanyFri 10/11/17 | 10:19
Holding(s) in CompanyWed 01/11/17 | 12:23
Holding(s) in CompanyMon 23/10/17 | 07:30
NXP001 agreement for pilot bioequivalence studyThu 19/10/17 | 07:00
Admission and First DealingsMon 16/10/17 | 07:00
Cancellation Notice and Re-AdmissionMon 16/10/17 | 07:00
Change of NameFri 13/10/17 | 15:44
Result of Meeting and Completion of AcquisitionFri 13/10/17 | 12:35
Half-year ReportFri 13/10/17 | 07:00
Final Results and Annual ReportFri 22/09/17 | 07:00
Prospectus re: Proposed Acquisition of NuformixFri 15/09/17 | 14:15